Joachim Peter Kaltwasser

Summary

Affiliation: Frankfurt am Main
Country: Germany

Publications

  1. ncbi Leflunomide in psoriatic arthritis
    Joachim Peter Kaltwasser
    Abt Rheumatologie, Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der J W Goethe Universitat, Frankfurt am Main, Theodor Stern Kay 7, D 60590 Frankfurt am Main, Germany
    Autoimmun Rev 6:511-4. 2007
  2. ncbi Erythropoietin and iron
    J P Kaltwasser
    Medizinische Klinik III, Zentrum der Inneren Medizin der J W Goethe Universität, Frankfurt am Main, Germany
    Kidney Int Suppl 69:S49-56. 1999
  3. ncbi Leflunomide: long-term clinical experience and new uses
    J Peter Kaltwasser
    Abteilung Rheumatologie, Medizinische Klinik III, Zentrum der Inneren Medizin, J W Goethe Universitat, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    Expert Opin Pharmacother 6:787-801. 2005
  4. ncbi Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial
    J Peter Kaltwasser
    Abteilung Rheumatologie, Medizinische Klinik III, Zentrum der Innere Medizin, J W Goethe Universitat, Frankfurt am Main, Germany
    Arthritis Rheum 50:1939-50. 2004
  5. ncbi [Assessment of the studies. Important recombinant agents in treatment of rheumatoid arthritis]
    Joachim Peter Kaltwasser

    Pharm Unserer Zeit 32:396-403. 2003
  6. ncbi Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis
    J P Kaltwasser
    Medizinische Klinik III, Bereich Rheumatologie, J W Goethe Universitat, Frankfurt Main, Germany
    J Rheumatol 28:2430-6. 2001
  7. ncbi Expression of interleukin-18 receptor in fibroblast-like synoviocytes
    Burkhard Möller
    Rheumazentrum Rhein Main, Marienburgstrasse 2, D 60528 Frankfurt, Germany
    Arthritis Res 4:139-44. 2002
  8. ncbi Prednisolone induces interleukin-18 expression in mononuclear blood and myeloid progenitor cells
    B Moller
    Klinikum der Johann Wolfgang Goethe Universitat, Medizinische Klinik III, Frankfurt, Germany
    Inflamm Res 51:457-63. 2002
  9. ncbi Interleukin-10 expression: is there a neglected contribution of CD8+ T cells in rheumatoid arthritis joints?
    B Moller
    Klinikum der Johann Wolfgang Goethe Universitat, Medizinische Klinik III, Frankfurt, Germany
    Clin Exp Rheumatol 20:813-22. 2002
  10. ncbi [Analysis of immunoglobulins and complement factors in synovial fluid and serum in rheumatoid arthritis, seronegative spondyloarthropathies and osteoarthritis: pathophysiology and retrospective analysis of clinical value]
    B Moller
    Rheumazentrum Rhein Main Klinikum der Johann Wolfgang Goethe Universität, Orthopädische Universitätsklinik Theodor Stern Kai 7 60590 Frankfurt M, Germany
    Z Rheumatol 61:48-57. 2002

Detail Information

Publications14

  1. ncbi Leflunomide in psoriatic arthritis
    Joachim Peter Kaltwasser
    Abt Rheumatologie, Medizinische Klinik II, Zentrum der Inneren Medizin, Klinikum der J W Goethe Universitat, Frankfurt am Main, Theodor Stern Kay 7, D 60590 Frankfurt am Main, Germany
    Autoimmun Rev 6:511-4. 2007
    ..It is therefore concluded that Leflunomide offers an efficacious, well tolerated, safe, and relatively inexpensive therapeutic option for the treatment of actively inflamed joints and psoriatic skin lesions in patients with PsA...
  2. ncbi Erythropoietin and iron
    J P Kaltwasser
    Medizinische Klinik III, Zentrum der Inneren Medizin der J W Goethe Universität, Frankfurt am Main, Germany
    Kidney Int Suppl 69:S49-56. 1999
    ..The diagnostic use of the serum transferrin receptor is presently limited because of limitations in methodology and definition (standardization) of reference ranges...
  3. ncbi Leflunomide: long-term clinical experience and new uses
    J Peter Kaltwasser
    Abteilung Rheumatologie, Medizinische Klinik III, Zentrum der Inneren Medizin, J W Goethe Universitat, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    Expert Opin Pharmacother 6:787-801. 2005
    ..New investigations with leflunomide have focused mainly on combination regimens for the treatment of RA and the use of leflunomide in other inflammatory or autoimmune disorders...
  4. ncbi Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial
    J Peter Kaltwasser
    Abteilung Rheumatologie, Medizinische Klinik III, Zentrum der Innere Medizin, J W Goethe Universitat, Frankfurt am Main, Germany
    Arthritis Rheum 50:1939-50. 2004
    ..We undertook this double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of leflunomide in patients with PsA and psoriasis...
  5. ncbi [Assessment of the studies. Important recombinant agents in treatment of rheumatoid arthritis]
    Joachim Peter Kaltwasser

    Pharm Unserer Zeit 32:396-403. 2003
  6. ncbi Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis
    J P Kaltwasser
    Medizinische Klinik III, Bereich Rheumatologie, J W Goethe Universitat, Frankfurt Main, Germany
    J Rheumatol 28:2430-6. 2001
    ..v.) iron influences health related quality of life (HRQoL) and clinical outcome including disease activity...
  7. ncbi Expression of interleukin-18 receptor in fibroblast-like synoviocytes
    Burkhard Möller
    Rheumazentrum Rhein Main, Marienburgstrasse 2, D 60528 Frankfurt, Germany
    Arthritis Res 4:139-44. 2002
    ..We conclude that the presence of macrophages or IL-18R+ T cells that can respond directly to IL-18 is essential for the proinflammatory effects of IL-18 in synovitis in RA...
  8. ncbi Prednisolone induces interleukin-18 expression in mononuclear blood and myeloid progenitor cells
    B Moller
    Klinikum der Johann Wolfgang Goethe Universitat, Medizinische Klinik III, Frankfurt, Germany
    Inflamm Res 51:457-63. 2002
    ..High levels of IL-18 expression in RA joints are contrasted by reduced IL-18 expression in RA peripheral blood mononuclear cells (PBMC). Here, we investigated a putative IL-18 regulating role of corticosteroids...
  9. ncbi Interleukin-10 expression: is there a neglected contribution of CD8+ T cells in rheumatoid arthritis joints?
    B Moller
    Klinikum der Johann Wolfgang Goethe Universitat, Medizinische Klinik III, Frankfurt, Germany
    Clin Exp Rheumatol 20:813-22. 2002
    ..To search for RA specific processes among T cell accumulation, T cell activation, or cytokine expression in CD4+ and CD8+ synovial fluid (SF) T cells...
  10. ncbi [Analysis of immunoglobulins and complement factors in synovial fluid and serum in rheumatoid arthritis, seronegative spondyloarthropathies and osteoarthritis: pathophysiology and retrospective analysis of clinical value]
    B Moller
    Rheumazentrum Rhein Main Klinikum der Johann Wolfgang Goethe Universität, Orthopädische Universitätsklinik Theodor Stern Kai 7 60590 Frankfurt M, Germany
    Z Rheumatol 61:48-57. 2002
    ..Synovial fluid (SF) analysis was a mandatory investigation in rheumatological practice. In recent time, synovial fluid analysis lost importance predominantly due to unclear defined guidelines for the practical use...
  11. ncbi Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin
    U Arndt
    Medizinische Klinik III, Klinikum der Johann Wolfgang Goethe Universitat, Theodor Stern Kai 7, 60590 Frankfurt, Germany
    Ann Hematol 84:159-66. 2005
    ..Retrospective analysis of the evaluable parameters (CHr, sTrfR, and ZnPP) revealed no additional benefit for predicting or monitoring IDE in this setting, although the one or other may be advantageous in other therapeutic situations...
  12. ncbi [Clinical day care treatment of patients with rheumatoid arthritis: concept of a new outcome-oriented evaluation project]
    B Moller
    Rheumazentrum Rhein Main Med Klinik III am Klinikum der Johann Wolfgang Goethe Universität und Rheumatologische Tagesklinik der Stiftung Friedrichsheim
    Z Rheumatol 59:128-30. 2000
    ..The paper contains a review of studies published in English or German language dealing with day-patient treatment of RA patients...
  13. ncbi Interferon-gamma induces expression of interleukin-18 binding protein in fibroblast-like synoviocytes
    B Moller
    Rheumazentrum Rhein Main Medizinische Klinik III, Frankfurt am Main, Germany
    Rheumatology (Oxford) 42:442-5. 2003
    ..To investigate expression of the endogenous antagonist of interleukin 18 (IL-18) bioactivity, IL-18 binding protein isoform a (IL-18BPa), in fibroblast-like synoviocytes (FLS)...
  14. ncbi Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Behçet's disease
    F Behrens
    Center of Rheumatology, , Frankfurt am Main, Germany
    Adv Exp Med Biol 528:561-2. 2003